Economy

Bristol Myers Reports CAR-T Death as Safety Concerns Mount

Bristol Myers Squibb Co. has reported a death in its clinical trials of an experimental cell therapy for autoimmune diseases, potentially adding to safety concerns about a promising new class of treatments.